303 related articles for article (PubMed ID: 31759953)
1. Left ventricular hypertrophy and hypertension.
Yildiz M; Oktay AA; Stewart MH; Milani RV; Ventura HO; Lavie CJ
Prog Cardiovasc Dis; 2020; 63(1):10-21. PubMed ID: 31759953
[TBL] [Abstract][Full Text] [Related]
2. Current Perspectives on Left Ventricular Geometry in Systemic Hypertension.
Oktay AA; Lavie CJ; Milani RV; Ventura HO; Gilliland YE; Shah S; Cash ME
Prog Cardiovasc Dis; 2016; 59(3):235-246. PubMed ID: 27614172
[TBL] [Abstract][Full Text] [Related]
3. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
5. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
6. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
[TBL] [Abstract][Full Text] [Related]
7. Physical Exercise Combined with Antihypertensive Drug Therapy on Left Ventricular Hypertrophy: Systematic Review and Meta-Analysis.
de Castro QJT; Tomaz FSC; Watai PY; Grabe-Guimarães A
High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):493-503. PubMed ID: 32776302
[TBL] [Abstract][Full Text] [Related]
8. Hypertension and Organ Damage in Women.
Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
[TBL] [Abstract][Full Text] [Related]
10. Geometrical and functional changes of left heart in adults with prehypertension and hypertension: a cross-sectional study from China.
Li T; Yang J; Guo X; Chen S; Sun Y
BMC Cardiovasc Disord; 2016 May; 16():114. PubMed ID: 27234840
[TBL] [Abstract][Full Text] [Related]
11. Association of Blood Pressure Control Level With Left Ventricular Morphology and Function and With Subclinical Cerebrovascular Disease.
Nakanishi K; Jin Z; Homma S; Elkind MSV; Rundek T; Tugcu A; Sacco RL; Di Tullio MR
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28757483
[TBL] [Abstract][Full Text] [Related]
12. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy.
Liebson PR; Serry RD
Curr Hypertens Rep; 2000 Jun; 2(3):260-70. PubMed ID: 10981159
[TBL] [Abstract][Full Text] [Related]
13. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
[TBL] [Abstract][Full Text] [Related]
14. Myocardial remodeling in hypertension.
Nadruz W
J Hum Hypertens; 2015 Jan; 29(1):1-6. PubMed ID: 24804791
[TBL] [Abstract][Full Text] [Related]
15. Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study.
Brown AJM; Lang C; McCrimmon R; Struthers A
BMC Cardiovasc Disord; 2017 Aug; 17(1):229. PubMed ID: 28835229
[TBL] [Abstract][Full Text] [Related]
16. High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis.
Cuspidi C; Sala C; Tadic M; Gherbesi E; Facchetti R; Grassi G; Mancia G
J Hypertens; 2019 Jul; 37(7):1312-1319. PubMed ID: 30829730
[TBL] [Abstract][Full Text] [Related]
17. Impact of hypertension with or without diabetes on left ventricular remodeling in rural Chinese population: a cross-sectional study.
Li T; Chen S; Guo X; Yang J; Sun Y
BMC Cardiovasc Disord; 2017 Jul; 17(1):206. PubMed ID: 28750662
[TBL] [Abstract][Full Text] [Related]
18. Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network.
Lønnebakken MT; Mancusi C; Losi MA; Gerdts E; Izzo R; Manzi MV; De Luca N; de Simone G; Trimarco B
Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):185-190. PubMed ID: 30559043
[TBL] [Abstract][Full Text] [Related]
19. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
[TBL] [Abstract][Full Text] [Related]
20. Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Antihypertensive Treatment in Stage I Hypertension. Results From the Prever-Treatment Study.
Bertoluci C; Foppa M; Santos ABS; Branchi TV; Fuchs SC; Fuchs FD
Am J Hypertens; 2018 Feb; 31(3):321-328. PubMed ID: 29036504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
